$BTC

🚨📣: South Korean biotechnology company Bridge Biotherapeutics has secured $183.3 million in funding from cryptocurrency investment firm Parataxis to build a Bitcoin vault.

- The company will change its brand name to Parataxis Korea and continue trading on the South Korean stock exchange KOSDAQ.

- Bridge joins other healthcare-related companies such as Semler Scientific and Prenetics Global in adopting a Bitcoin vault strategy.

- Parataxis is preparing for a U.S. public offering via a special purpose acquisition company.